Leblon Tiphaine, Riolet Clemence, Ennezat PierreVladimir, Marechaux Sylvestre
Lille Catholic hospitals, Heart Valve Center, Cardiology Department, ETHICS EA 7446, Lille Catholic University, France.
Henri Monder University Hospital, Cardiology department, Paris, France.
Eur Heart J Case Rep. 2021 Dec 16;6(1):ytab516. doi: 10.1093/ehjcr/ytab516. eCollection 2022 Jan.
Drug-induced valvular heart disease (DI-VHD) is a well-defined condition associated with specific pathology features. However, clinical presentations may broadly vary and thereby make DI-VHD diagnosis more challenging.
We report two patients with a history of benfluorex administration, who developed extensive mitral calcific lesions which evolved towards caseous necrosis.
Prospective follow-up over several years of these two patients who initially had typical DI-VHD findings provided monitoring evidence of extensive calcifications and subsequent caseous necrosis. These reports suggest a link between calcific heart injury and benfluorex exposure. The diagnosis of DI-VHD may be overlooked at this late stage.
药物性瓣膜性心脏病(DI-VHD)是一种具有明确病理特征的疾病。然而,其临床表现可能差异很大,从而使DI-VHD的诊断更具挑战性。
我们报告了两名有服用苄氟雷司病史的患者,他们出现了广泛的二尖瓣钙化病变,并发展为干酪样坏死。
对这两名最初有典型DI-VHD表现的患者进行了数年的前瞻性随访,提供了广泛钙化及随后干酪样坏死的监测证据。这些报告提示钙化性心脏损伤与苄氟雷司暴露之间存在关联。在疾病晚期,DI-VHD的诊断可能会被忽视。